Glutathione (GSH) Probes (Ursa Bioscience, 2013)
However, the risk increases meaningfully when retatrutide is used alongside insulin or sulphonylureas, and this combination requires careful clinical monitoring
10.1016/S0378-4320(02)00018-0 82
Tolerability and Side Effects Both forms may cause nausea, vomiting, reduced appetite, or gastrointestinal discomfort, particularly during dose escalation
Patients with history of pancreatitis should discuss risks carefully with healthcare providers
At present, there are no large, randomised studies that directly compare the effects of these two drugs on overall survival rate